Help Theodore Fight a
Rare Tumor
Theodore was diagnosed with a Melanotic Neuroectodermal Tumor of Infancy (MNTI) — one of the rarest and most aggressive tumors in pediatric medicine — just two months after he was born.
Donate NowGoal: $35,000 — Every dollar goes directly to Theodore's medical care
2 mo
Age at diagnosis
<500
MNTI cases ever documented
$35K
GoFundMe goal
See Theodore's Journey
Watch on InstagramTheodore's Story
About two months after Theodore was born, his family noticed something was wrong. What they discovered was devastating: a Melanotic Neuroectodermal Tumor of Infancy (MNTI) — a tumor so rare that most specialists have never seen one in their entire careers.
The tumor destroyed part of Theodore's upper jaw and cranial bone. It began affecting his ability to breathe and eat, quickly becoming life-threatening. His family in Miami Beach scrambled to find specialists who could help.
Surgery required a team of specialists — several of whom, with decades of experience, had never personally treated a case this severe. Theodore's case is now formally studied in the medical literature due to its rarity and severity.
The pathology reports raise concerns about remaining margins, which may require additional procedures. Craniofacial specialists have indicated that the damage from the tumor will likely require long-term reconstruction and monitoring throughout childhood and into adolescence — including bone grafting, jaw support, and dental rehabilitation as he grows.
Because MNTI is so rare, much of Theodore's specialized care is out-of-network. Insurance complications mean a significant portion of his care will be out of pocket. The financial burden on the family is immense — on top of everything else they are dealing with.
What is MNTI?
Melanotic Neuroectodermal Tumor of Infancy (MNTI) is an extremely rare neoplasm that affects infants, typically in the first year of life. Fewer than 500 cases have ever been documented in the medical literature worldwide.
MNTI most commonly appears in the upper jaw (maxilla) and can destroy bone rapidly. While classified as benign, the tumor is locally aggressive — it can erode through bone, affect breathing and feeding, and has a recurrence rate of approximately 15-20% after surgery.
Treatment typically requires radical surgical excision by a team of specialists including pediatric oncologists, craniofacial surgeons, and reconstructive surgeons. Long-term follow-up is critical due to recurrence risk and the need for reconstructive procedures as the child grows.
How You Can Help
Donate
Any amount helps. Medical bills for rare conditions are staggering.
Share
Share this page or the GoFundMe link. Visibility saves lives.
Send Love
Prayers, positive energy, good vibes — Theodore's family feels every one.
A note from Glen
I know Theodore's dad personally. He's a good man going through something no parent should ever have to face. Theodore is fighting a tumor that most doctors have never even seen. The medical bills are real, the out-of-pocket costs are brutal, and the family is under extraordinary pressure. I'm sharing this because I know my community shows up when it matters. If you can give — give. If you can share — share. Either one makes a difference.
— Glen Bradford, glenbradford.com
Share Theodore's Story
Direct GoFundMe link: gofundme.com/f/please-support-theodores-long-road-to-healing-from-mnti
Get Glen's Musings
Occasional thoughts on AI, Claude, investing, and building things. Free. No spam.
Unsubscribe anytime. I respect your inbox more than Congress respects property rights.